Inventor
Alexandros Makriyannis
Inventor
Watertown, MA, US
Overview
Patents· 54 as inventor
Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.
C07Dprimary
C07DHeterocyclic compounds39%
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations25%
C07CAcyclic or carbocyclic compounds17%
A61KPreparations for medical, dental or toiletry purposes12%
C07FAcyclic, carbocyclic or heterocyclic compounds containing elements other than carbon, hydrogen, halogen, oxygen, nitrogen, sulfur, selenium or tellurium4%
C07BGeneral methods of organic chemistry3%
C07JSteroids1%
G01NInvestigating or analysing materials by determining their chemical or physical properties1%
PatentTitleYear
10,968,206Cannabinergic nitrate esters and related analogs202110,882,838Cannabinergic compounds and uses thereof202110,689,357N-acylethanolamine hydrolyzing acid amidase (NAAA) inhibitors and use thereof202010,662,159ABHD6 and dual ABHD6/MGL inhibitors and their uses202010,640,494N-acylethanolamine hydrolyzing acid amidase (NAAA) inhibitors and their use thereof202010,570,146Urea/carbamates FAAH MAGL or dual FAAH/MAGL inhibitors and uses thereof202010,221,164Cannabinergic nitrate esters and related analogs201910,053,444Cannabinergic nitrate esters and related analogs20189,963,444N-acylethanolamine hydrolyzing acid amidase (NAAA) inhibitors and their use thereof20189,580,400'Cannabinergic nitrate esters and related analogs'20179,517,989'2-cycloalkyl resorcinol cannabinergic ligands'20169,271,962'Inhibitors of fatty acid amide hydrolase and monoacylglycerol lipase for modulation of cannabinoid receptors'20169,102,622'Fatty acid amide hydrolase inhibitors'20158,853,205'Heteropyrrole analogs acting on cannabinoid receptors'20148,410,097'Heteropyrrole analogs acting on cannabinoid receptors'20138,293,724'Therapeutic applications of fatty acid amide hydrolase inhibitors'20128,293,211'CB1 receptor antagonists and uses thereof'20128,202,893'Cannabinergic lipid ligands'20128,097,752'Antiprotozoal ring-substituted phospholipids'20128,084,451'Heteropyrrole analogs acting on cannabinoid receptors'20118,084,467'Pyrazole derivatives as cannabinoid receptor antagonists'20117,897,598'Inhibitors of the anandamide transporter'20117,820,144'Receptor selective cannabimimetic aminoalkylindoles'20107,745,440'Pyrazole analogs acting on cannabinoid receptors'20107,741,365'Peripheral cannabinoid receptor (CB2) selective ligands'20107,666,867'Heteroindanes: a new class of potent cannabimimetic ligands'20107,589,220'Inhibitors of the anandamide transporter'20097,446,229'Bicyclic cannabinoids'20087,393,842'Pyrazole analogs acting on cannabinoid receptors'20087,335,688'Bicyclic cannabinoid agonists for the cannabinoid receptor'20087,329,651'Cannabimimetic ligands'20087,285,683'Bicyclic and tricyclic cannabinoids'20077,276,613'Retro-anandamides, high affinity and stability cannabinoid receptor ligands'20077,241,799'Cannabimimetic indole derivatives'20077,183,313'Keto cannabinoids with therapeutic indications'20077,173,027'Receptor selective cannabimimetic aminoalkylindoles'20077,161,016'Cannabimimetic lipid amides as useful medications'20077,119,108'Pyrazole derivatives as cannabinoid receptor antagonists'20067,115,657'Bifunctional agents possessing antioxidant and antiarrhythmic activity'20067,064,116'GABAA modulating neurosteroids'20067,057,076'Bicyclic and tricyclic cannabinoids'20066,995,187'Peripheral cannabinoid receptor (CB2) selective ligands'20066,943,266'Bicyclic cannabinoid agonists for the cannabinoid receptor'20056,939,977'Analgesic and immunomodulatory cannabinoids'20056,900,236'Cannabimimetic indole derivatives'20056,579,900'Anandamide amidase inhibitors as analgesic agents'20036,391,909'Anandamide inhibitors as analgesic agents'20026,166,066'Cannabinoids selective for the CB2 receptor'20005,874,459'Anandamide amidase inhibitors as analgesic agents'19995,872,148'Compositions useful as a cannabinoid receptor probe'19995,744,459'Phospholipid compounds and use therefor'19985,688,825'Anandamide amidase inhibitors as analgesic agents'19975,489,580'Phospholipid compounds and use therefor'19965,440,052'Compositions useful as a cannabinoid receptor probe'1995Career & activity timeline
Assembled from patent assignee/location history and declaration credentials.
1995–2018Patents assigned to UNIV CONNECTICUT (37)· patent assignee history
1995–2003Based in Ashford, CT, US· patent location history
2005–2021Based in Watertown, MA, US· patent location history
2005–2010Based in Mystic, CT, US· patent location history
2006–2016Patents assigned to MAKRIYANNIS ALEXANDROS (12)· patent assignee history
2006–2012Patents assigned to CALOGEROPOULOU THEODORA (2)· patent assignee history
2006–2018Based in Boston, MA, US· patent location history
2011Based in Storrs, CT, US· patent location history
2012–2020Patents assigned to MAKSCIENTIFIC LLC (3)· patent assignee history
2016–2021Patents assigned to UNIV NORTHEASTERN (10)· patent assignee history
Inventor activity
Assignee and location history derived from the patent record.
Assignees
| Assignee | Patents | Span |
|---|---|---|
| UNIV CONNECTICUT | 37 | 1995–2018 |
| MAKRIYANNIS ALEXANDROSself | 12 | 2006–2016 |
| UNIV NORTHEASTERN | 10 | 2016–2021 |
| MAKSCIENTIFIC LLC | 3 | 2012–2020 |
| CALOGEROPOULOU THEODORA | 2 | 2006–2012 |
Locations
| Location | Patents | Span |
|---|---|---|
| Watertown, Massachusetts, US | 32 | 2005–2021 |
| Mystic, CT, US | 10 | 2005–2010 |
| Ashford, CT, US | 8 | 1995–2003 |
| Boston, Massachusetts, US | 2 | 2006–2018 |
| Storrs, CT, US | 1 | 2011 |